Scholarlink

Objective <p>This study evaluated associations between several obesity indicators and the risks of Crohn’s disease (CD) and ulcerative colitis (UC), the two principal clinical phenotypes of inflammatory bowel disease (IBD).</p> Methods <p>Data from 479,590 UK Biobank participants (mean age ± standard deviation: 56.5 ± 8.09 years; 54.5% female) were analyzed. Participants were classified based on waist circumference (WC). Cox proportional hazards models were used to quantify associations between multiple adiposity measures and incident CD and UC, adjusting for demographic, behavioral, and clinical covariates.</p> Results <p>During a median observation period of 12.5 years (maximum 15.6 years), 1,518 incident CD cases and 2,957 incident UC cases were identified. Taking into account demographic variables (age, sex, and ethnic background), lifestyle indicators (including smoking, alcohol intake, sleep, diet, physical exercise, and employment), socioeconomic status measured by the Townsend Deprivation Index(TDI), coexisting conditions (hypertension and diabetes), inflammatory status (C-reactive protein), and nonsteroidal anti-inflammatory drug consumption, waist-to-hip ratio (WHR)–defined central adiposity was found to elevate the risk of CD (hazard ratio [HR] 1.18; 95% confidence interval [CI] 1.05–1.34). However, WC-defined central obesity did not demonstrate a statistically significant link to CD risk (HR 1.11, 95% CI 0.97–1.27). In minimally adjusted models, WHR-defined central obesity was associated with an increased hazard of UC (HR 1.13; 95% CI 1.05–1.23); this association attenuated to non-significance after full covariate adjustment (HR 1.03; 95% CI 0.95–1.13). Obesity defined by BMI ≥ 30 showed no relation to CD, whereas it was associated with a lower hazard of UC (HR 0.86; 95% CI 0.78–0.95). Similarly, higher body-fat percentage (BFP: male &gt; 25%, female &gt; 35%) was associated with a modestly lower hazard of CD (HR 0.92; 95% CI 0.85–0.99). Excluding incident IBD events that occurred during the first 24 months of follow-up, the WHR–CD association persisted (HR 1.19; 95% CI 1.04–1.36). Additionally, individuals in the highest third of WHR-for-BMI residuals (&gt; 66th percentile) exhibited a markedly elevated risk of CD (HR 1.26; 95% CI 1.10–1.44).</p> Conclusions <p>Central obesity, assessed by WHR, independently predicts the risk of CD, with a particularly pronounced effect in females, irrespective of BMI or other metabolic confounders. Conversely, higher BMI and BFP were inversely associated with UC risk.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Central obesity measured by waist-to-hip ratio independently predicts crohn’s disease risk: a prospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月29日

查看全文
  • Lei Sun,
  • Shengxuan Zhang,
  • Jinghao Pan,
  • Yue Lv,
  • Yichen Zhou,
  • Siqi Chen,
  • Xiong Chen,
  • Xun Hu,
  • Quanhong Li,
  • Wei Ye,
  • Jingru Song

摘要

Objective

This study evaluated associations between several obesity indicators and the risks of Crohn’s disease (CD) and ulcerative colitis (UC), the two principal clinical phenotypes of inflammatory bowel disease (IBD).

Methods

Data from 479,590 UK Biobank participants (mean age ± standard deviation: 56.5 ± 8.09 years; 54.5% female) were analyzed. Participants were classified based on waist circumference (WC). Cox proportional hazards models were used to quantify associations between multiple adiposity measures and incident CD and UC, adjusting for demographic, behavioral, and clinical covariates.

Results

During a median observation period of 12.5 years (maximum 15.6 years), 1,518 incident CD cases and 2,957 incident UC cases were identified. Taking into account demographic variables (age, sex, and ethnic background), lifestyle indicators (including smoking, alcohol intake, sleep, diet, physical exercise, and employment), socioeconomic status measured by the Townsend Deprivation Index(TDI), coexisting conditions (hypertension and diabetes), inflammatory status (C-reactive protein), and nonsteroidal anti-inflammatory drug consumption, waist-to-hip ratio (WHR)–defined central adiposity was found to elevate the risk of CD (hazard ratio [HR] 1.18; 95% confidence interval [CI] 1.05–1.34). However, WC-defined central obesity did not demonstrate a statistically significant link to CD risk (HR 1.11, 95% CI 0.97–1.27). In minimally adjusted models, WHR-defined central obesity was associated with an increased hazard of UC (HR 1.13; 95% CI 1.05–1.23); this association attenuated to non-significance after full covariate adjustment (HR 1.03; 95% CI 0.95–1.13). Obesity defined by BMI ≥ 30 showed no relation to CD, whereas it was associated with a lower hazard of UC (HR 0.86; 95% CI 0.78–0.95). Similarly, higher body-fat percentage (BFP: male > 25%, female > 35%) was associated with a modestly lower hazard of CD (HR 0.92; 95% CI 0.85–0.99). Excluding incident IBD events that occurred during the first 24 months of follow-up, the WHR–CD association persisted (HR 1.19; 95% CI 1.04–1.36). Additionally, individuals in the highest third of WHR-for-BMI residuals (> 66th percentile) exhibited a markedly elevated risk of CD (HR 1.26; 95% CI 1.10–1.44).

Conclusions

Central obesity, assessed by WHR, independently predicts the risk of CD, with a particularly pronounced effect in females, irrespective of BMI or other metabolic confounders. Conversely, higher BMI and BFP were inversely associated with UC risk.